Meletios Karas
Endocrinology, Diabetes & Metabolism · Fort Wayne, INNPI 1205887098
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 101 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 11.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,263 and has fallen 96.8% since, to $41 in 2021. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in IN, where the typical reported total is $1,569.
Across 101 payments — averaging $15.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$183
- Amgen$180
- Sanofi-aventis U.S. LLC$168
- AstraZeneca$159
- Insulet Corporation$111
- Pfizer$85
- plus $683 from 18 others
What the payments were for
- Food & beverage$1,569100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 6 | $183 |
| Amgen(2 entities) | 16 | $180 |
| Sanofi-aventis U.S. LLC | 12 | $168 |
| AstraZeneca | 12 | $159 |
| Insulet Corporation | 7 | $111 |
| Pfizer | 6 | $85 |
| Mannkind Corporation | 5 | $74 |
| Amneal Pharmaceuticals LLC | 3 | $72 |
| Abbott | 5 | $72 |
| Shire North American Group Inc | 3 | $58 |
| Boehringer Ingelheim | 4 | $58 |
| AbbVie | 3 | $49 |
| Johnson & Johnson | 2 | $46 |
| Dexcom, Inc. | 2 | $45 |
| Corcept Therapeutics | 3 | $40 |
| Tandem Diabetes Care, Inc. | 2 | $33 |
| Medtronic | 2 | $27 |
| Lilly USA, LLC | 2 | $24 |
| Companion Medical, Inc. | 1 | $17 |
| Regeneron Healthcare Solutions, Inc. | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Lifescan, Inc. | 1 | $13 |
| Merck | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$106
How this compares
$1,569 in reported general payments places this provider in the 50th percentile of 134 endocrinology, diabetes & metabolism providers in Indiana.
See all endocrinology, diabetes & metabolism providers in Indiana →
Other endocrinology, diabetes & metabolism in Fort Wayne
- H BeyerFort Wayne$7K
- Isaiah PittmanTerre Haute$1.5M
- Ernest AsamoahIndianapolis$959K
- Erica KretchmanRichmond$609K
- Emily VeenemanSeymour$583K
- Nihad MuhrezMerrillville$271K
- Hisham AllababidiIndianapolis$195K
- Neha GavinFishers$149K
- Edward RicoTerre Haute$135K
- Dona GrayLafayette$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.